Factor | Excellent efficacy group (n = 50) | General efficacy group (n = 62) | t/χ2/Z | P |
---|---|---|---|---|
Age (years) | 51.5 ± 3.1 | 51.1 ± 3.4 | 0.629 | 0.531 |
BMI (kg/m2) | 23.01 ± 1.62 | 23.22 ± 1.92 | 0.618 | 0.538 |
Marital status | 0.615 | 0.735 | ||
Married | 40 (80.00) | 53 (85.48) | ||
Unmarried | 3 (6.00) | 3 (4.84) | ||
Divorced | 7 (14.00) | 6 (9.68) | ||
Past medical history | ||||
Hypertension | 15 (30.00) | 21 (33.87) | 0.190 | 0.436 |
Diabetes | 10 (20.00) | 22 (35.48) | 3.252 | 0.071 |
Hyperlipidemia | 12 (24.00) | 18 (29.03) | 0.357 | 0.550 |
Coronary heart disease | 5 (10.00) | 7 (11.29) | 0.048 | 0.826 |
Place of residence | 0.047 | 0.828 | ||
City | 42 (84.00) | 53 (85.48) | ||
Rural area | 8 (16.00) | 9 (14.52) | ||
Degree of education | 0.155 | 0.734 | ||
≥ Senior high school | 34 (68.00) | 44 (70.97) | ||
< Senior high school | 16 (32.00) | 18 (29.03) | ||
Causes | 0.303 | 0.860 | ||
Falling down | 35 (70.00) | 46 (74.19) | ||
Sprain | 10 (20.00) | 10 (16.13) | ||
Other | 5 (10.00) | 6 (9.68) | ||
Site of injury vertebrae | −1.142 | 0.254 | ||
T7 | 4 (6.56) | 6 (7.23) | ||
T8 | 0 (0.00) | 2 (2.41) | ||
T9 | 2 (3.28) | 3 (3.61) | ||
T10 | 4 (6.56) | 5 (6.02) | ||
T11 | 4 (6.56) | 7 (8.43) | ||
T12 | 11 (18.03) | 20 (24.10) | ||
L1 | 12 (19.67) | 14 (16.87) | ||
L2 | 8 (13.11) | 10 (12.05) | ||
L3 | 8 (13.11) | 7 (8.43) | ||
L4 | 6 (9.84) | 6 (7.23) | ||
L5 | 2 (3.28) | 3 (3.61) | ||
Use of zoledronic acid | 3.949 | 0.047 | ||
Used | 32 (64.00) | 28 (45.16) | ||
Unused | 18 (36.00) | 34 (54.84) | ||
Fracture acuteness | ||||
Acute | 30 (60.00) | 36 (58.06) | ||
Subacute | 20 (40.00) | 26 (41.94) | ||
Peripheral vertebrae wall damage | 2.637 | 0.104 | ||
Damaged | 8 (16.00) | 18 (29.03) | ||
Undamaged | 42 (84.00) | 44 (70.97) | ||
Bone cement dosage (mL) | 5.08 ± 1.43 | 5.19 ± 1.01 | 0.479 | 0.633 |
TNF-α (pg/mL) | 5.86 ± 1.81 | 6.08 ± 2.06 | 0.595 | 0.553 |
IL-6 (pg/mL) | 11.03 ± 3.14 | 11.21 ± 3.40 | 0.289 | 0.773 |
BMD (g/cm2) | 0.95 ± 0.21 | 0.92 ± 0.14 | 0.908 | 0.366 |
PINP (μg/L) | 55.93 ± 5.82 | 55.18 ± 5.51 | 0.701 | 0.485 |
BGP (μg/L) | 4.16 ± 0.73 | 4.13 ± 0.84 | 0.200 | 0.842 |
Vertebral height ratios of injured vertebrae (%) | 75.02 ± 10.63 | 69.29 ± 9.19 | 6.822 | < 0.001 |
Cobb angle (°) | 15.98 ± 2.15 | 17.55 ± 3.54 | 2.757 | 0.007 |
VAS score | 3.04 ± 1.65 | 2.80 ± 1.25 | 0.879 | 0.381 |
ODI score | 26.52 ± 10.15 | 38.55 ± 7.30 | 7.322 | < 0.001 |